A pilot initiative has commenced in the state of Utah where artificial intelligence will be employed for renewing prescriptions for certain psychiatric medications. This marks only the second instance in the US where AI has been afforded such authority. State officials contend that this program is intended to curb expenses and address the shortage of mental health professionals, notwithstanding the wariness expressed by medical practitioners regarding the safety and efficacy of this methodology.
The system, created by Legion Health, authorizes a chatbot to extend prescriptions for 15 low-risk medications, including fluoxetine (Prozac), sertraline (Zoloft), and bupropion (Wellbutrin). To qualify for participation, individuals must verify their identity, furnish proof of a prior prescription, and satisfy stringent prerequisites: no dosage adjustments or hospitalizations within the last year, alongside mandatory physician consultations every six months or after ten prescription renewals.
The platform is incapable of issuing novel prescriptions or managing medications necessitating close clinical oversight, such as controlled substances, benzodiazepines, or antipsychotics. Drugs requiring monitoring via blood work, for example, lithium, are also excluded.
Patients utilizing the system respond to inquiries concerning symptoms, adverse effects, and medication effectiveness. Should responses breach predefined parameters, the case is escalated for physician review. Initially, within this pilot program, the first 1,250 requests will undergo mandatory specialist vetting, followed by a random review process targeting 5–10% of subsequent requests.
Legion Health representatives assert that automating the renewal workflow will enable patients to access necessary care more rapidly and affordably, allowing clinicians to dedicate attention to more intricate situations. Nevertheless, certain psychiatrists harbor reservations about the program’s success. They highlight potential hazards linked to the AI’s opacity, alongside the possibility of misjudgments when evaluating patient conditions.
Legion Health intends to broaden its scope to encompass additional states, ultimately aiming for nationwide availability of the service.
About the Author
